| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |